NDC00062-1552-01: OFLOXACIN IN DEXTROSE INJECTION.
OFLOXACIN IN DEXTROSE INJECTION. Key specifications include administration: INTRAVENOUS INFUSION, special_features: 400 MG OFLOXACIN; 4 MG PER ML; IN 5 PCT DEXTROSE, primary_container_type: BOTTLE, therapeutic_equivalent: FLOXIN BY ORTHO PHARM., total_primary_container_quantity: 12, primary_container_content_quantity: 100.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-364-4123, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS INFUSION |
| special_features | 400 MG OFLOXACIN; 4 MG PER ML; IN 5 PCT DEXTROSE |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | FLOXIN BY ORTHO PHARM. |
| total_primary_container_quantity | 12 |
| primary_container_content_quantity | 100.000 MILLILITERS |
| part_name_assigned_by_controlling_agency | OFLOXACIN IN DEXTROSE INJECTION 4MG/ML 100ML BT 12S |
| NSN | 6505-01-364-4123 |
| THERAPEUTIC EQUIVALENT | FLOXIN BY ORTHO PHARM. |
| ADMINISTRATION | INTRAVENOUS INFUSION |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | 400 MG OFLOXACIN; 4 MG PER ML; IN 5 PCT DEXTROSE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | OFLOXACIN IN DEXTROSE INJECTION 4MG/ML 100ML BT 12S |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |